background
presenc
atopi
consid
risk
factor
sever
respiratori
symptom
children
object
studi
examin
effect
atopi
cours
diseas
children
hospitalis
viral
pneumonia
method
children
age
year
hospitalis
due
viral
pneumonia
year
includ
multicentr
studi
patient
classifi
two
group
mild
moder
sever
accord
cours
pneumonia
presenc
atopi
evalu
skin
prick
test
group
compar
evalu
risk
factor
associ
sever
viral
pneumonia
result
total
patient
nine
centr
includ
studi
patient
male
respiratori
syncyti
viru
influenza
rhinoviru
adenoviru
human
metapneumoviru
parainfluenza
coronaviru
bocaviru
isol
respiratori
sampl
eightyf
children
sever
pneumonia
atop
sensitis
found
patient
ever
wheez
rr
ci
parent
asthma
rr
ci
allerg
diseas
famili
rr
ci
environment
tobacco
smoke
rr
ci
common
sever
pneumonia
group
abbrevi
rv
rhinoviru
rsv
respiratori
syncyti
viru
hmpv
human
metapneumoviru
rtpcr
realtim
revers
transcript
polymeras
chain
reaction
spt
skin
prick
test
bmi
bodi
mass
index
et
environment
tobacco
smoke
exposur
interact
asthma
viral
infect
known
long
time
attent
drawn
mani
studi
decreas
antivir
respons
patient
asthma
epithelium
damag
disrupt
epithelium
repair
mechan
inflamm
insuffici
immun
respons
occur
asthma
caus
patient
becom
sensit
airway
irrit
well
viral
infect
atopi
refer
genet
tendenc
develop
allerg
diseas
allerg
rhiniti
asthma
atop
dermat
viral
infect
disrupt
integr
epithelium
barrier
way
synerg
effect
respiratori
tract
damag
respiratori
epithelium
caus
onset
inflamm
thu
trigger
wheez
episod
asthma
inflamm
respiratori
tract
due
atopi
addit
disrupt
epitheli
barrier
integr
place
patient
risk
sever
viral
lower
respiratori
tract
infect
atop
children
risk
sever
pneumonia
pandem
influenza
epidem
also
first
rhinoviru
rv
infect
patient
asthma
gener
form
lower
respiratori
tract
infect
sever
last
longer
put
forth
prospect
cohort
studi
risk
hospitalis
due
sever
respiratori
syncyti
viru
rsv
infect
greater
atop
children
comparison
control
group
also
report
asthma
atop
dermat
increas
risk
pneumococc
infect
recent
studi
show
atop
sensitis
emerg
prior
respiratori
tract
infect
viral
ill
allerg
sensitisationexposur
increas
risk
sever
respiratori
tract
diseas
requir
hospitalis
object
studi
examin
effect
presenc
atopi
cours
diseas
children
hospitalis
viral
pneumonia
hypothesis
atop
children
increas
risk
sever
pneumonia
viral
infect
children
age
year
hospitalis
viral
pneumonia
includ
multicentr
prospect
studi
case
chronic
diseas
includ
asthma
gastroesophag
reflux
tracheomalacia
tuberculosi
congenit
heart
diseas
cystic
fibrosi
primari
ciliari
dyskinesia
vascular
ring
bronchopulmonari
dysplasia
immun
defici
exclud
studi
present
symptom
patient
laboratori
find
radiolog
find
durat
hospitalis
record
atopi
defin
posit
skin
prick
test
spt
one
allergen
viru
detect
identif
carri
nasopharyng
aspir
exampl
via
realtim
revers
transcript
polymeras
chain
reaction
rtpcr
method
fast
track
diagnost
luxembourg
ari
presenc
atopi
evalu
skin
prick
test
spt
particip
spt
dermatophagoid
pteronyssinu
dermatophagoid
farina
alternaria
alternata
cat
grass
mix
phleum
pratens
poa
pratensi
dactyli
glomerata
lolium
perenn
festuca
pratensi
avena
eliat
tree
mix
betula
verrucosa
alnu
glutinosa
coryllu
avellena
olea
europea
blatella
germanica
histamin
neg
control
standardis
core
allergen
extract
control
provid
alkabello
horsholm
denmark
test
administ
use
prick
test
devic
volar
surfac
forearm
record
min
consid
posit
mean
wheal
diamet
mm
larger
compar
neg
control
posit
spt
defin
wheal
mm
one
allergen
spt
patient
receiv
corticosteroid
therapi
perform
four
week
hospit
discharg
hand
spt
perform
complet
pneumonia
treatment
patient
receiv
steroid
patient
classifi
two
group
mild
moder
sever
accord
cours
pneumonia
patient
consid
sever
pneumonia
least
one
follow
criteria
present
spo
ambient
air
stage
intens
care
mechan
ventil
support
requir
develop
atelectasi
effus
impair
conscious
tendenc
sleep
lethargi
confus
unrespons
pain
stimul
excess
dehydr
apnoea
risk
factor
may
caus
sever
viral
pneumonia
cours
examin
risk
factor
includ
gender
bodi
mass
index
bmi
educ
statu
famili
whether
influenza
vaccin
given
environment
tobacco
smoke
exposur
et
presenc
atop
diseas
patient
presenc
atop
diseas
famili
caus
agent
type
allergen
presenc
pet
data
analysi
carri
via
spss
ibm
statist
window
version
ibm
corpar
armonk
new
york
unit
state
medcalc
acacialaan
ostend
belgium
softwar
shapiro
wilk
test
use
examin
whether
data
fit
normal
distribut
varianc
homogen
data
examin
via
leven
test
independentsampl
test
togeth
bootstrap
result
use
compar
two
independ
group
mann
whitney
u
test
use
mont
carlo
simul
techniqu
pearson
chisquar
fisher
exact
test
test
via
mont
carlo
simul
techniqu
comparison
categor
data
rel
risk
valu
calcul
order
examin
ratio
develop
diseas
risk
factor
logist
regress
test
use
calcul
oddsratio
quantit
explanatori
variabl
statist
signific
binari
diotom
respons
variabl
quantit
data
express
tabl
mean
sd
standard
deviat
median
iqr
interquartil
rang
median
rang
maximum
minimum
valu
categor
data
express
n
number
percentag
data
examin
confid
level
p
valu
less
accept
statist
signific
approv
taken
izmir
dr
uz
child
diseas
padiatr
surgeri
train
research
hospit
nonpharmacolog
clinic
studi
ethic
council
total
patient
differ
geograph
region
turkey
includ
studi
total
patient
whose
medic
record
miss
could
includ
studi
male
averag
age
min
max
month
bmi
min
max
averag
durat
hospitalis
min
max
day
viral
agent
includ
rsv
influenza
rhinoviru
adenoviru
human
metapneumoviru
hmpv
parainfluenza
coronaviru
bocaviru
histori
atopi
famili
question
parent
asthma
famili
histori
allerg
rhiniti
eczema
fooddrug
allergi
famili
fortyeight
percent
patient
ever
wheez
allerg
rhiniti
eczema
fooddrug
allergi
environment
tobacco
smoke
exposur
present
patient
famili
educ
statu
evalu
mother
highschool
educ
father
highschool
educ
three
percent
patient
receiv
influenza
vaccin
pet
home
tabl
atopi
found
patient
frequent
sensitis
mite
grasspollen
mixtur
alternaria
atopi
frequent
patient
influenza
rhinoviru
infect
p
statist
signific
differ
found
atop
patient
older
compar
nonatop
patient
viral
pneumonia
p
one
hundr
ninetyf
patient
mild
moder
sever
pneumonia
compar
patient
mild
moder
pneumonia
patient
sever
pneumonia
found
carri
significantli
greater
rel
risk
rr
term
ever
wheez
rr
ci
parent
asthma
rr
allerg
diseas
famili
rr
ci
et
rr
ci
respect
educ
statu
parent
exist
pet
whether
patient
famili
member
influenza
vaccin
year
past
associ
sever
pneumonia
tabl
surprisingli
patient
sever
pneumonia
longer
durat
hospitalis
p
bodi
mass
index
lower
p
children
sever
pneumonia
lower
number
lymphocyt
p
eosinophil
p
higher
number
neutrophil
p
compar
mild
moder
group
atopi
detect
children
sever
pneumonia
mild
moder
pneumonia
p
even
though
statist
signific
differ
found
term
atopi
group
sever
pneumonia
ever
wheez
p
parent
asthma
p
observ
frequent
children
sever
pneumonia
tabl
studi
effect
atop
sensitis
sever
viral
pneumonia
children
howev
histori
allerg
diseas
ever
wheez
atop
dermat
fooddrug
allergi
associ
sever
pneumonia
natur
acquir
immun
airway
insuffici
asthma
airway
epithelium
chemic
physic
immunolog
barrier
addit
hold
cell
togeth
airway
epithelium
tight
junction
region
act
protect
barrier
prevent
harm
molecul
infecti
agent
enter
tissu
prevent
passag
intracellular
gap
molecul
ion
shown
patient
asthma
sensit
allergen
environment
irrit
due
defect
epithelium
barrier
children
gener
face
hous
allergen
first
year
live
risk
develop
asthma
increas
result
sensit
allergen
shown
studi
exposur
lung
epithelium
allergen
proteolyt
activ
housedust
mite
pollen
mould
fungi
caus
increas
epithelium
permeabl
separ
tight
junction
region
epithelium
cell
respiratori
tract
virus
enter
airway
epithelium
replic
airway
epithelium
thu
damag
ciliat
noncili
respiratori
tract
epithelium
cell
result
caus
necrosi
ciliostasi
loss
cilia
decreas
mucociliari
clearanc
airway
epithelium
atopi
viral
infect
caus
loss
integr
epithelium
barrier
vital
import
due
synerg
effect
respiratori
tract
fortytwo
percent
children
hospitalis
intens
care
unit
pandem
influenza
epidem
asthmaatop
sensitis
sever
respiratori
tract
infect
common
atop
children
comparison
nonatop
children
anoth
studi
carri
year
children
asthma
attack
pandem
influenza
epidem
asthma
attack
receiv
protect
treatment
asthma
wherea
first
asthma
attack
sever
asthma
attack
pneumonia
atelectasi
develop
easili
atop
patient
howev
differ
determin
season
influenza
studi
presenc
atopi
skin
prick
test
risk
factor
sever
viral
pneumonia
howev
show
ever
wheez
parent
asthma
relat
atop
structur
associ
sever
pneumonia
volunt
subject
vivo
rv
inocul
asthma
sever
symptom
comparison
control
experiment
rv
studi
show
allerg
sensitis
exposur
allergen
relat
increas
sever
rv
relat
lower
respiratori
tract
infect
asthma
exacerb
ducharm
fm
et
al
show
almost
twothird
patient
predominantli
preschool
age
six
year
older
virus
detect
nasopharyng
secret
mainli
rv
rsv
studi
influenza
rv
pneumonia
frequent
atop
children
support
previou
find
effect
pollut
cigarett
gener
neglect
exist
allergen
virus
comparison
made
children
hospitalis
commun
acquir
pneumonia
durat
hospitalis
children
two
smoke
famili
member
hous
longer
intensivecar
need
greater
previou
studi
report
et
gambian
alaskan
children
smoke
mother
finnish
children
relat
invas
pneumococc
diseas
jroundi
et
al
show
smoke
hous
associ
wors
prognosi
children
pneumonia
expect
et
signific
risk
factor
sever
pneumonia
studi
jung
et
al
report
allerg
diseas
asthma
atop
dermat
also
increas
risk
pneumococc
infect
also
show
risk
sever
pneumonia
increas
time
p
histori
eczema
even
simpl
nutrit
chang
may
effect
prevent
virusinduc
diseas
lower
bodi
mass
index
bmi
case
sever
pneumonia
indic
import
nutrit
support
virusrel
pneumonia
lazzerini
et
al
show
pneumonia
relat
fatal
rate
increas
case
malnutrit
studi
jroundi
et
al
support
find
show
prognosi
wors
children
weightforag
z
score
ahanchian
et
al
point
nutrit
support
decreas
recurr
lower
respiratori
tract
infect
children
jroundi
et
al
studi
children
pneumonia
show
cyanosi
pale
prematur
passiv
smoke
risk
factor
wors
prognosi
ever
wheez
asthma
stori
jackson
et
al
report
low
birth
weight
lack
exclus
breastfeed
crowd
seven
person
per
household
exposur
indoor
air
pollut
incomplet
immunis
undernutrit
weightforag
less
two
standard
deviat
hiv
infect
risk
factor
sever
pneumonia
children
age
five
year
direct
relationship
could
shown
presenc
atopi
sever
pneumonia
studi
howev
presenc
ever
wheez
allerg
diseas
stori
parent
asthma
associ
wors
pneumonia
camara
et
al
carri
studi
children
age
report
atopi
histori
famili
children
age
two
inhal
allergen
sensit
children
age
two
risk
factor
viral
respiratori
tract
infect
find
accord
studi
kusel
et
al
evalu
children
age
six
month
two
five
ten
year
old
sever
viral
respiratori
tract
infect
regard
atopi
rate
atopi
increas
two
year
age
increas
age
time
age
ten
relationship
observ
case
sever
rsv
infect
earli
age
averag
age
children
atopi
greater
comparison
age
without
atopi
studi
p
perhap
differ
result
may
obtain
vitro
method
sige
use
instead
spt
detect
presenc
atopi
earli
age
one
limit
studi
atop
statu
monitor
period
interv
et
al
examin
effect
sever
bronchiol
pneumonia
infantil
period
teenag
asthma
report
repeat
wheez
atop
dermat
elev
blood
eosinophil
earli
asthmapredict
factor
also
observ
studi
repeat
wheez
accompani
stori
allerg
diseas
relat
sever
pneumonia
relat
persist
respiratori
problem
socioeconom
statu
remark
mani
studi
howev
famili
gener
want
say
actual
level
incom
could
evalu
econom
statu
directli
tri
indirectli
evalu
accord
educ
level
say
socioeconom
level
patient
parent
gener
middl
class
educ
statu
parent
associ
sever
pneumonia
atopi
determin
risk
factor
sever
pneumonia
possibl
use
variou
treatment
modal
children
earli
age
thu
prevent
develop
sever
pneumonia
persist
wheez
asthma
develop
later
age
thu
prevent
prevent
sever
pneumonia
earli
age
studi
even
though
presenc
atopi
risk
factor
sever
pneumonia
histori
atopi
patient
sever
lower
respiratori
tract
infect
may
indic
diseas
may
follow
sever
cours
atop
patient
decreas
exposur
allergen
addit
decreas
et
may
also
decreas
risk
sever
lower
respiratori
tract
infect
confidenti
data
author
declar
follow
protocol
work
centr
public
patient
data
patient
includ
studi
receiv
suffici
inform
given
inform
consent
write
particip
studi
right
privaci
inform
consent
author
obtain
inform
consent
patient
andor
subject
mention
articl
author
correspond
possess
document
author
declar
procedur
follow
accord
regul
respons
clinic
research
ethic
committe
accord
world
medic
associ
helsinki
declar
extern
fund
secur
studi
author
financi
relationship
relev
articl
disclos
